Effects of Cholinesterase Inhibitors on Visual Attention in Mild Alzheimer's Disease

被引：0
|
作者：
Daiello, Lori A. [1 ]
Ott, Brian R. [1 ]
Festa, Elena K. [2 ]
Heindel, William C. [2 ]
机构：
[1] Rhode Isl Hosp, Alzheimers Dis & Memory Disorders Ctr, Providence, RI USA
[2] Brown Univ, Dept Psychol, Providence, RI 02912 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] Cholinesterase inhibitors selectively benefit attention and executive function in Alzheimer's disease (AD)
    Behl, P.
    Black, S.
    Lanctot, K.
    Streiner, D.
    BRAIN AND COGNITION, 2006, 62 (01) : 85 - 85
  • [22] Cholinesterases in Alzheimer’s disease and Cholinesterase inhibitors in Alzheimer therapy
    Z. Rakonczay
    I. Kovács
    Acta Biologica Hungarica, 1998, 49 (1): : 55 - 70
  • [23] Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer therapy
    Rakonczay, Z
    Kovács, I
    ACTA BIOLOGICA HUNGARICA, 1998, 49 (01): : 55 - 70
  • [24] Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia
    Han, Jee-young
    Besser, Lilah M.
    Xiong, Chengjie
    Kukull, Walter A.
    Morris, John C.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (02): : 87 - 94
  • [25] COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE
    Turongkaravee, S.
    VALUE IN HEALTH, 2010, 13 (07) : A502 - A502
  • [26] Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer’s disease
    Colin Green
    Joanna Picot
    Emma Loveman
    Andrea Takeda
    Jo Kirby
    Andrew Clegg
    PharmacoEconomics, 2005, 23 : 1271 - 1282
  • [27] Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease
    Bosanquet, N
    Yeates, A
    PHARMACOECONOMICS, 2006, 24 (06) : 623 - 625
  • [28] Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?
    Giacobini, E
    CNS DRUGS, 2001, 15 (02) : 85 - 91
  • [29] Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer’s Disease?
    Ezio Giacobini
    CNS Drugs, 2001, 15 : 85 - 91
  • [30] Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease
    Green, C
    Picot, J
    Loveman, E
    Takeda, A
    Kirby, J
    Clegg, A
    PHARMACOECONOMICS, 2005, 23 (12) : 1271 - 1282
12345